Maria Claudia Costa

Robust Feature Selection strategy detects a panel of microRNAs as putative diagnostic biomarkers in Breast Cancer

T. Noviello, L. Cerulo, Michele Ceccarelli, 2023, bioRxiv.

Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and correlation with integrated, multiomic analysis in the NIBIT-M4 trial

T. Noviello, C. Sautès-Fridman, G. Pruneri, 2023, medRxiv.

Identification of therapeutic targets in osteoarthritis by combining heterogeneous transcriptional datasets, drug-induced expression profiles, and known drug-target interactions

M. Franzese, Concetta Iside, Marco Salvatore, 2024, Journal of translational medicine.

Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the phase 1b NIBIT-M4 trial

T. Noviello, C. Sautès-Fridman, A. Anichini, 2023, Nature communications.

Epigenetic remodeling to improve the efficacy of immunotherapy in human glioblastoma: pre-clinical evidence for development of new immunotherapy approaches

T. Noviello, A. Anichini, R. Mortarini, 2024, Journal of translational medicine.